Shengrong Wan

705 total citations · 1 hit paper
16 papers, 427 citations indexed

About

Shengrong Wan is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Shengrong Wan has authored 16 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Clinical Biochemistry. Recurrent topics in Shengrong Wan's work include Diet and metabolism studies (4 papers), Diet, Metabolism, and Disease (3 papers) and Pancreatic function and diabetes (3 papers). Shengrong Wan is often cited by papers focused on Diet and metabolism studies (4 papers), Diet, Metabolism, and Disease (3 papers) and Pancreatic function and diabetes (3 papers). Shengrong Wan collaborates with scholars based in China, Macao and United States. Shengrong Wan's co-authors include Zongzhe Jiang, Yong Xu, Bu-tuo Xu, Yang Long, Ying An, MA Xiu-mei, Xiaozhen Tan, Man Guo, Fang‐Yuan Teng and Kang Geng and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Shengrong Wan

16 papers receiving 422 citations

Hit Papers

The role of oxidative stress in diabetes mellitus-induced... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengrong Wan China 11 135 91 89 84 50 16 427
Yuliya V. Markina Russia 11 160 1.2× 102 1.1× 100 1.1× 58 0.7× 50 1.0× 42 472
Wenqian Zhang China 9 144 1.1× 120 1.3× 97 1.1× 42 0.5× 42 0.8× 32 437
Jianhua Zhu China 11 195 1.4× 74 0.8× 136 1.5× 112 1.3× 45 0.9× 21 452
Xiaozhen Tan China 13 269 2.0× 55 0.6× 78 0.9× 64 0.8× 28 0.6× 27 504
Hideyuki Kabasawa Japan 11 176 1.3× 42 0.5× 79 0.9× 85 1.0× 50 1.0× 34 553
Neeraj Ramakrishnan United States 5 84 0.6× 123 1.4× 94 1.1× 81 1.0× 61 1.2× 8 330
Maria Soledad Pizarro-Sánchez Spain 5 178 1.3× 58 0.6× 102 1.1× 41 0.5× 22 0.4× 7 447
Jia‐Feng Chang Taiwan 16 161 1.2× 60 0.7× 79 0.9× 38 0.5× 32 0.6× 46 560
Sergio Sánchez‐Enríquez Mexico 14 109 0.8× 71 0.8× 76 0.9× 83 1.0× 32 0.6× 36 592

Countries citing papers authored by Shengrong Wan

Since Specialization
Citations

This map shows the geographic impact of Shengrong Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengrong Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengrong Wan more than expected).

Fields of papers citing papers by Shengrong Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengrong Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengrong Wan. The network helps show where Shengrong Wan may publish in the future.

Co-authorship network of co-authors of Shengrong Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Shengrong Wan. A scholar is included among the top collaborators of Shengrong Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengrong Wan. Shengrong Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xu, Bu-tuo, Shengrong Wan, Yufeng Xing, et al.. (2025). BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2. Cardiovascular Diabetology. 24(1). 101–101. 9 indexed citations
2.
Xu, Huili, Shengrong Wan, Ying An, et al.. (2024). Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discovery. 10(1). 399–399. 24 indexed citations
3.
Zeng, Chen, et al.. (2024). Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases. Biomedicine & Pharmacotherapy. 177. 117065–117065. 12 indexed citations
4.
Wan, Shengrong, Ying An, Wei Fan, Fang‐Yuan Teng, & Zongzhe Jiang. (2023). Comparative transcriptomic analysis reveals the underlying molecular mechanism in high-fat diet-induced islet dysfunction. Bioscience Reports. 43(7). 2 indexed citations
5.
Wan, Shengrong, Fang‐Yuan Teng, Wei Fan, et al.. (2023). BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway. Aging. 15(22). 13384–13410. 18 indexed citations
6.
An, Ying, Bu-tuo Xu, Shengrong Wan, et al.. (2023). The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovascular Diabetology. 22(1). 237–237. 171 indexed citations breakdown →
7.
An, Ying, Kang Geng, Hongya Wang, et al.. (2023). Hyperglycemia-induced STING signaling activation leads to aortic endothelial injury in diabetes. Cell Communication and Signaling. 21(1). 365–365. 24 indexed citations
8.
An, Ying, Kang Geng, Shengrong Wan, et al.. (2023). High glucose-induced endothelial STING activation inhibits diabetic wound healing through impairment of angiogenesis. Biochemical and Biophysical Research Communications. 668. 82–89. 24 indexed citations
9.
Fan, Wei, Zongzhe Jiang, & Shengrong Wan. (2023). Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis. Medicine. 102(46). e35887–e35887. 4 indexed citations
10.
Xu, Bu-tuo, Fang‐Yuan Teng, Shengrong Wan, et al.. (2022). Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model. Cell Death Discovery. 8(1). 49–49. 27 indexed citations
11.
Xu, Bu-tuo, Jing Wu, Yueli Pu, et al.. (2022). Maresin 1 Alleviates Diabetic Kidney Disease via LGR6‐Mediated cAMP‐SOD2‐ROS Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 7177889–7177889. 20 indexed citations
12.
Guo, Man, Zongzhe Jiang, Yan Zeng, et al.. (2021). Chronic Ethanol Consumption Induces Osteopenia via Activation of Osteoblast Necroptosis. Oxidative Medicine and Cellular Longevity. 2021(1). 3027954–3027954. 20 indexed citations
13.
Xu, Huiwen, Jingyu Liu, Xiaozhen Tan, et al.. (2021). Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms. Journal of Diabetes Research. 2021. 1–11. 43 indexed citations
14.
Wan, Shengrong, Man Guo, Qing Chen, et al.. (2020). Impact of Exposure to Antibiotics During Pregnancy and Infancy on Childhood Obesity: A Systematic Review and Meta‐Analysis. Obesity. 28(4). 793–802. 26 indexed citations
15.
Wan, Shengrong, Fang‐Yuan Teng, Zongzhe Jiang, & Yong Xu. (2020). 484-P: Abnormal Ketone Body Metabolism Caused by Bdh1 Deficiency Promoted the Progression of Diabetic Kidney Disease by Activating ROS. Diabetes. 69(Supplement_1). 1 indexed citations
16.
Jiang, Zongzhe, Shengrong Wan, & Bowen Xing. (2019). Wild-type menin is rapidly degraded via the ubiquitin-proteasome pathway in a rat insulinoma cell line. Bioscience Reports. 39(10). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026